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Abstract 
Members of the coiled-coil-helix-coiled-coil-helix (CHCH) domain-containing protein family 
that carry (CX9C) type motifs are imported into the mitochondrion with the help of the 
disulfide relay-dependent MIA import pathway. These evolutionary-conserved proteins are 
emerging as new cellular factors that control mitochondrial respiration, redox regulation, lipid 
homeostasis or membrane ultrastructure and dynamics. Here, we discuss recent insights on 
the activity of known (CX9C) motif-carrying proteins in mammals and review current data 
implicating the MIA40/CHCHD4 import machinery in the regulation of their mitochondrial 
import. Recent findings and the identification of disease-associated mutations in specific 
(CX9C) motif-carrying proteins have highlighted members of this family of proteins as 
potential therapeutic targets in a variety of human disorders.  
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Mitochondrial protein import: Historical background and its discovery  1	  
Mitochondria play a quintessential role in normal metabolism [1, 2] and lethal signaling 2	  
processes in the context of physiological or pathological cell death [3, 4]. Mutations in 3	  
mitochondrial proteins, be they encoded by the mitochondrial or nuclear genomes, have been 4	  
associated with multiple diseases including cancer, metabolic disorders, neurodegenerative 5	  
pathologies, diabetes and premature aging [5-8].  6	  
 7	  
A hypothetical reconstruction of cellular evolution postulates that some two billion years ago 8	  
the organelle appeared in the eukaryotic cell by the engulfment of an endosymbiotic 9	  
prokaryotic organism.	  This endosymbiotic relationship was consolidated by the progressive 10	  
incorporation of originally bacterial genes into the nuclear genome [9, 10], thereby improving 11	  
the integration of mitochondria in various aspects of cellular metabolism [1, 2, 6, 9-12]. 12	  
Modern cells control mitochondrial function at several levels by regulating (i) the 13	  
transcription of nuclear genes, (ii) the cytoplasmic translation of mRNAs, as well as (iii) the 14	  
import of the proteins into one of the four subcompartments, namely the outer and inner 15	  
membranes, the matrix and the intermembrane space [5, 13, 14].  16	  
 17	  
The mitochondrial genome of human cells encodes only 13 proteins, while the function of the 18	  
organelle requires the import of >1000 nuclear-encoded proteins [13, 14]. Studies in yeast 19	  
revealed that most of the nuclear-encoded mitochondrial proteins pass into the organelle 20	  
through one general entry gate at the outer membrane, the outer membrane translocase (TOM), 21	  
which contains the protein Tom40 as its central protein-conducting channel. However, after 22	  
engaging with the TOM translocon, mitochondrial proteins follow different sorting routes, 23	  
dictated by specific targeting codes in their sequence or overall structure that guide them to 24	  
their final destination. Additional translocase machineries like the sorting and assembly 25	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machinery (SAM) complex in the outer membrane, the presequence translocase TIM23 26	  
complex and the carrier translocase TIM22 complex, both located in the inner membrane and 27	  
the MIA40 complex in the intermembrane space (IMS) decode the import signals to finally 28	  
dispatch each protein toward the appropriate submitochondrial compartment [1, 2, 11, 12]. 29	  
Recently, the mitochondrial import (MIM) complex that is localized in the outer 30	  
mitochondrial membrane was revealed to be necessary for the import of α-helical outer 31	  
membrane proteins that bypass the TOM complex [2]. Mitochondrial import activity can be 32	  
influenced by the differentiation and activation states of the cell or impacted by pathological 33	  
conditions such as oxidative stress, aging and imminent cell death [2]. Human disease-34	  
associated mutations can affect either the mitochondrial-targeting segment of the nuclear-35	  
encoded proteins or specific components of the import machinery [2, 6, 8, 15, 16].  36	  
 37	  
The characterization of the mitochondrial import process has led to the discovery of a family 38	  
of nuclear-encoded proteins, the coiled-coil-helix-coiled-coil-helix (CHCH) domain 39	  
(CHCHD) containing proteins, which are imported in the mitochondrial intermembrane space 40	  
where they participate to activities such as mitochondrial biogenesis, bioenergetics, dynamics 41	  
or quality control. These proteins are imported with the help of the evolutionary conserved 42	  
redox active Mia40/CHCHD4 import machinery that catalyzes their oxidative folding through 43	  
a disulfide relay system [1, 16] (Figure 1, Key Figure). Here, we review current knowledge 44	  
on this fascinating family of proteins. 45	  
 46	  
Import into the mitochondrial intermembrane space  47	  
The intermembrane space (IMS) constitutes an essential crossroad for the physiological 48	  
communication of mitochondria with the rest of the cell [16, 17], as well as for lethal 49	  
signaling processes [4]. Upon mitochondrial outer membrane permeabilization (MOMP), 50	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which is generally associated with apoptosis [3], a series of proteins that are normally 51	  
confined in the IMS such as apoptosis-inducing factor (AIF), cytochrome c, endonuclease G, 52	  
HtrA2 peptidase and Diablo homolog are released from the IMS to the extramitochondrial 53	  
space, where they contribute to cellular dismantling [18, 19].  54	  
 55	  
Proteomic analyses conducted in S. cerevisiae [20] or in human cells [21] revealed that all 56	  
IMS-confined proteins are nuclear-encoded, with their number ranging between 50 to 130. 57	  
IMS proteins that carry an N-terminal mitochondrial localization sequence (MLS) engage 58	  
with the matrix-targeting TIM23 complex, but then either become attached to the inner 59	  
membrane facing the IMS or get released into the IMS as soluble proteins, following the 60	  
proteolytic cleavage of their N-terminal presequence [1, 2]. A second class of IMS-localized 61	  
proteins does not possess such an N-terminal targeting sequence. Instead, their import is 62	  
coupled to cofactor-triggered or redox-regulated folding events that stabilize and trap them in 63	  
the IMS [16, 17, 22]. Cofactor-triggered IMS entrapment is exemplified by the heme-64	  
dependent import and maturation of cytochrome c, which is orchestrated by the activity of 65	  
cytochrome c heme lyase (CCHL) [17]. The oxidation-driven import of cysteine motif-66	  
carrying proteins depends on a “disulfide relay” pathway that is controlled by the 67	  
evolutionary conserved oxidoreductase Mia40/CHCHD4 [1, 16, 17, 22]. 68	  
 69	  
The Mia40/CHCHD4 protein import machinery and its substrates from yeast to man 70	  
The oxidative folding-coupled, Mia40-dependent import of small nuclear-encoded cysteine 71	  
rich proteins into the mitochondrial IMS was initially discovered in the yeast Saccharomyces 72	  
cerevisiae. The oxidoreductase Mia40, its central component [23-27], acts as an import 73	  
receptor that performs two functions. During an initial ‘sliding step’ the peptide-binding cleft 74	  
of Mia40 specifically binds to the internal IMS-specific Targeting Signal (called ITS or 75	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MISS) of the incoming precursor proteins via hydrophobic interactions. In the subsequent 76	  
‘docking step’, Mia40 binds covalently via an intermolecular disulfide bond engaging the 77	  
active site CPC tripeptide of the Mia40 to one cysteine of the substrate [28]. Thus, Mia40 acts 78	  
as a chaperone that induces the folding of the substrate in the first ‘sliding’ step, followed by 79	  
a disulfide donor function in the second ‘docking’ step. The end result of this process is the 80	  
catalyzed oxidative folding and entrapment of the substrate in the IMS [16, 22, 29, 30]. At the 81	  
end of its catalytic cycle, after donating a disulfide to the substrate, the Mia40 CPC motif is 82	  
reduced. The reoxidation of the CPC motif is ensured by the FAD-linked sulfhydryl oxidase 83	  
Erv1 (human equivalent: ALR) [31-33]. This step is mediated specifically by the natively 84	  
disordered N-terminal segment of Erv1 [34] that contains a CX2C motif. The pair of electrons 85	  
that are released during the formation of the disulfide bond are subsequently transferred in a 86	  
cascade of reactions from the N-terminal CX2C motif of Erv1 (C30/C33) to its FAD-proximal 87	  
CX2C pair (C130/C133), onto the flavin moiety, and then to cytochrome c, cytochrome 88	  
oxidase (COX) and finally molecular oxygen. Alternatively, Erv1-released electrons can be 89	  
absorbed by cytochrome C peroxidase (Ccp1) [35]. Although it is known that this pathway 90	  
can operate under anaerobic conditions, the final electron acceptor in these situations is still 91	  
elusive.  92	  
 93	  
Even though the principal catalytic and structural features of Mia40, in particular within the 94	  
segment that contains the redox active cysteine-proline-cysteine (CPC) and the (CX9C)2 95	  
motifs, have been conserved throughout eukaryotic evolution [27, 36-40], there are important 96	  
differences between yeast and mammals. In contrast to yeast Mia40 (~40 kDa), human 97	  
CHCHD4 does not possess an N-terminal presequence and hence lacks a membrane anchor 98	  
[27, 36-38, 40]. Thus, CHCHD4 is a relatively small (16 kDa) soluble protein that is no 99	  
longer imported via the TIM23 translocase but rather relies on a self-catalytic import process 100	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[36, 37]. This switch in the import pathway might have occurred during evolution to couple 101	  
the import of CHCHD4 more tightly to the IMS redox-signaling pathway, perhaps to achieve 102	  
rapid adaptive responses in mitochondria responding to ever changing metabolic needs. 103	  
CHCHD4 has lost its hydrophobic inner membrane anchor, yet has acquired the capacity to 104	  
interact with a new partner, the flavoprotein AIF [40], which is attached to the inner 105	  
membrane [41, 42]. The N-terminal 27 residues of CHCHD4 are necessary and sufficient to 106	  
establish a direct interaction with AIF [40]. Nuclear magnetic resonance (NMR) spectroscopy 107	  
indicates that the AIF-binding domain of CHCHD4 is part of an N-terminal unstructured lid 108	  
segment that includes the redox-active center CPC [27]. However, far-UV circular dichroism 109	  
(CD) spectroscopy analysis suggests that upon its interaction with AIF, the AIF-binding 110	  
segment of CHCHD4 undergoes important conformational rearrangements that may well 111	  
affect the interactions of the CHCHD4 CPC domain with its incoming substrates or its 112	  
reoxidizing partner ERV1/ALR [40]. The conformational status of AIF, which is determined 113	  
by the binding of its cofactor NADH [43], appears crucial for its interaction with CHCHD4. 114	  
Addition of NADH enhances the interaction between CHCHD4 and AIF, yet fails to do so 115	  
when AIF is mutated (G308E) in its NADH-binding domain [40]. Thus far it is not known 116	  
whether the redox activity of AIF (which is an NADH oxidase) directly affects CHCHD4 as 117	  
an electron acceptor.  118	  
 119	  
Prototypic substrates of the redox-active MIA import pathway share conserved coiled coil-120	  
helix1-coiled coil-helix 2 (CHCH) domains (CHCHD) containing within each helix two 121	  
cysteines that are organized as CxnC motifs [1, 44]. Typical Mia40 substrates are proteins of 122	  
less than 25 kDa that carry double cysteine-x3-cysteine (Cx3C)2 or double cysteine-x9-cysteine 123	  
(Cx9C)2 motifs [45-47] (BOX 1). Recent studies have revealed that Mia40 substrates are not 124	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limited to CXnC-containing precursors but also include proteins with alternate cysteine motifs 125	  
that are not organized in a CHCH domain (BOX1). 126	  
 127	  
C-X9-C domain-containing proteins in health and disease 128	  
Mia40 substrates that carry (CX9C)2 motifs participate to a large array of activities that are 129	  
related to the biogenesis of respiratory chain complexes, lipid homeostasis or mitochondrial 130	  
dynamics [16, 46-48] (Figure 1, Key Figure). The doubling of the number of substrates 131	  
during evolution from yeast to man [46, 47, 49] and the discovery of human disease-132	  
associated mutations affecting members of this family (Table 2) reflect the 133	  
pathophysiological relevance of the MIA import pathway as they offer challenging 134	  
opportunities to decipher the molecular activity of each of them.  135	  
 136	  
Biogenesis of Respiratory chain complexes  137	  
Beyond the aforementioned connection between Mia40/CHCHD4 and Erv1/ALR (which 138	  
establishes electron flow from Mia40/CHCHD4 to the respiratory chain) (see BOX 1), Mia40 139	  
has been linked to small (CX9C)2  motif-bearing proteins such as Cmc1, Cmc2, Cox6B, Coa4, 140	  
Coa5, Coa6, Cox17, Cox 19 and Cox23 that are implicated in the biogenesis and assembly of 141	  
respiratory chain complex CIV (cytochrome C oxidase, COX) [16, 46-50] (Table 1). 142	  
Similarly, in mammals, the abundance of CHCHD4 (or that of its partner ALR) correlated 143	  
with respiratory chain activity and the oxidation kinetics of subunits CMC1, COA4 (also 144	  
called CMC3) and COX19 [39]. In human cells, the expression levels of CHCHD4 (or that of 145	  
its binding partner AIF) and the CIV complex copper chaperone COX17 correlate [36, 40]. 146	  
Indeed, NMR analyses indicate that human COX17 interacts with CHCHD4 via an 147	  
intermolecular disulfide bond [29, 48]. Missense mutations in several of these CHCHD4 148	  
substrates are implicated in human diseases (Table 2). For instance, a missense mutation in 149	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the human homolog of the yeast Cox12 (COX6B1), which carries an imperfect (CX9C)2 150	  
cysteine motif, is associated with a severe infantile encephalomyopathy [49, 51](Tables 1 151	  
and 2). Mutations in the CIV assembly factor COA5 (the human ortholog of yeast Pet191) 152	  
[47, 52]), which carries a typical (CX9C)2 motif, can give rise to a mitochondrial 153	  
cardiomyopathy [53]. Mutations in yet another CIV assembly factor, COA6, which contains 154	  
an unusual cysteine motif[20, 54], destabilize the newly synthesized mitochondrial DNA-155	  
encoded subunit COX2 and lead to neonatal hypertrophic cardiomyopathy [54-58] (Tables 1 156	  
and 2). 157	  
 158	  
Beyond the evolutionary-conserved substrates implicated in the biogenesis of complex CIV 159	  
(conserved from yeast to mammals), subunits of complex CI (NDUFB7, NDUFS5, NDUFA8 160	  
and NDUFS8) have made their appearance on the list of potential Mia40/CHCHD4 substrates 161	  
(Table1) [39, 49]. Among this group of (CX9C)2 motif-carrying proteins, NDUFB7 and 162	  
NDUFA8 are IMS-localized and likely stabilize the assembled CI complex by binding to its 163	  
surface [59]. NDUFA8 carries a duplicated (CX9C)2 motif, and the kinetics of its 164	  
mitochondrial import are controlled by CHCHD4 and ALR [39]. One of the complex core I 165	  
units NDUFS8, which is one of the longest human CHCHD containing proteins [49], carries a 166	  
potential mitochondrial localization presequence at its N terminus (MitoProt II-v1.101[60]). 167	  
Mutations in NDUFS8 can manifest as Leigh syndrome [61] (Table 2). 168	  
 169	  
In addition to the above-mentioned potential CHCHD4 substrates, the post-transcriptional 170	  
biogenesis of several other protein subunits of the respiratory chain complexes CI, CIII and 171	  
CIV is indirectly regulated by the CHCHD4-dependent import pathway [40, 62]. For instance, 172	  
in mammalian cells, AIF depletion negatively affects the expression of nuclear-encoded 173	  
subunits in CI (NDUFA9, NDUFS7, NDUFB6, NDUFB8 and NDUFA13) and CIII (UQCR1, 174	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UQCR2 and UQCRFS1), as well as that of the mitochondrial-encoded CIV subunit, COX2, in 175	  
a tissue-specific fashion [40, 62]. This consequence of AIF depletion can be reversed by the 176	  
expression of a CHCHD4 variant whose mitochondrial import does not depend on AIF [40], 177	  
establishing that CHCHD4 operates downstream of AIF.  178	  
 179	  
Mitochondrial lipid homeostasis 180	  
In yeast, the Mia40-regulated import machinery controls mitochondrial phospholipid 181	  
homeostasis via the Mia40/Erv1-dependent import of the (CX9C)2 type motif-carrying 182	  
substrate Mdm35, with wide consequences for membrane ultrastructure, mitochondrial 183	  
dynamics and activity [46]. Within the IMS, Mdm35 stably interacts with members of the 184	  
evolutionary-conserved UPS/PRELI-like proteins UPS1 and UPS2 [63-68], which mediate 185	  
the transfer of phospholipids between the outer and inner mitochondrial membranes. For 186	  
instance, UPS1 controls the transfer of phosphatidic acid (PA) from the outer to the inner 187	  
membrane, where PA is channeled into a chain of enzymatic reactions resulting in the 188	  
production of cardiolipin (CL)[65, 66, 69]. 189	  
 190	  
The human orthologue of Mdm35 is TRIAP1 (TP53-regulated inhibitor of apoptosis 1; also 191	  
called p53CSV for p53-inducible cell-survival factor) [47, 49, 70]. TRIAP1 and its 192	  
downstream effector PRELI (homologous to yeast Ups1) are necessary for the production of 193	  
cardiolipin (CL), which affects oxidative phosphorylation and impacts the apoptotic response 194	  
stimuli [71-74]. In physiological conditions, optimal electron transfer activity of cytochrome c 195	  
requires its CL-mediated electrostatic interaction with the inner membrane. Depletion of 196	  
TRIAP1 or PRELI reduces the content of CL within the inner membrane, reduces the 197	  
attachment of cytochrome c to the inner membrane and favors its mitochondrial release, thus 198	  
sensitizing cells to apoptosis induction (MOMP)[3, 18, 74]. Thus, the supply of exogenous 199	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phosphatidylglycerol (PG), one of the intermediates of CL biosynthesis, partially restores the 200	  
susceptibility of TRIAP1-deficient cells to lethal stimuli [71, 74]. Of note, TRIAP1 was 201	  
initially identified as a TP53-responsive anti-apoptotic protein that was induced in conditions 202	  
of sub-lethal genotoxic stress [70, 75] as well as a TP53 antagonist at the level of cell cycle 203	  
regulation [76]. TRIAP1 overexpression was reported for multiple myeloma [77] and breast 204	  
cancer [78] (Table 2). It will be important to define whether the putative function of TRIAP1 205	  
as an oncogene is linked to its functional interaction with TP53 or rather to its impact on 206	  
mitochondrial physiology.  207	  
 208	  
Mitochondrial morphology, remodeling and dynamics 209	  
Mitochondria constantly adapt their ultrastructure to meet the oscillating bioenergetic 210	  
demands of the cell [79]. While some membrane-anchored proteins such as mitofusin type 211	  
transmembrane GTPases (MFN1 and MFN2) and dynamin-related GTPases (DRP1 and 212	  
OPA1) orchestrate the fusion and division processes that control the number and the shape of 213	  
the organelle, others are required for the appropriate folding of the inner membrane and its 214	  
contact with the outer membrane [79]. This latter set of proteins controls the creation of inner 215	  
membrane microdomains, impact the number and shape of cristae and the formation of cristae 216	  
junctions. Among these are the evolutionary-conserved architectural proteins that participate 217	  
to the inner membrane associated complex, MICOS, which couples mitochondrial import to 218	  
the bioenergetic status of the organelle [79, 80]. The redox-regulated Mia40-dependent import 219	  
machinery is connected to the MICOS complex by regulating the import and oxidation of its 220	  
protein subunits [80-84].  221	  
 222	  
The evolutionary-conserved MIC19 (alias CHCHD3) (Tables 1) is a myristoylated inner 223	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membrane-bound protein that interacts with the peripheral surface of the MICOS complex, 224	  
facing the IMS, where its presence is necessary for cristae formation and communication with 225	  
the outer mitochondrial membrane [80, 85-92]. While, the implication of the (CX9C)2 motif 226	  
carrying protein MIC19 in the MICOS complex is well documented, the molecular basis for 227	  
the cell-specific regulation of its import and/or mitochondrial accumulation by the CHCHD4-228	  
dependent import machinery needs further characterization [40, 81, 93]. A search for rare 229	  
copy number variations has identified the human MIC19 locus as a candidate risk factor for 230	  
attention deficit hyperactivity disorder (ADHD)[94] (Table 2). Moreover, abnormal 231	  
expression of MIC19 protein has been associated with pathological metabolism conditions 232	  
[95, 96] (Table 2). MIC25 (known also as CHCHD6) is the metazoan homolog of yeast 233	  
Mic19, which was also identified as a (CX9C)2 motif-carrying subunit of the MICOS complex 234	  
[49, 80, 88, 97] (Table 1). While MIC19 was established as a crucial component of MICOS, 235	  
MIC25 seems to fulfill a more peripheral function, and its role in cristae formation still needs 236	  
to be established [88, 91, 97].  237	  
In human cells, the activity of the soluble IMS-localized (CX9C)2 motif-carrying protein 238	  
CHCHD10 (Table 1), which is enriched in cristae junctions, impacts mitochondrial 239	  
ultrastructure through hitherto poorly understood mechanisms [98]. A missense mutation 240	  
(S59L) in CHCHD10 that is associated with frontotemporal dementia (FTD) and amyotrophic 241	  
lateral sclerosis (ALS) [98, 99] causes respiratory deficiencies accompanied by mitochondrial 242	  
dysgenesis and fragmentation in patient fibroblasts [98] (Table 2). CHCHD10 and its 243	  
paralogue CHCHD2, which are encoded by genes localized on chromosomes 22q11.23 and 244	  
7p11.2, respectively, have emerged as a result of gene duplication during the evolution from 245	  
yeast to man [49]. Human CHCHD2 is essential for optimal respiratory activity [100-102], in 246	  
particular that of CIV [100, 102]. CHCHD2 depletion reduces the expression of the mtDNA-247	  
encoded COX2 subunit of CIV [100]. Indeed, bioinformatic analyses of natural variations in 248	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human gene expression suggest that CHCHD2 is implicated in the mitochondrial protein 249	  
translation [103]. Missense mutations in CHCHD2 are associated with autosomal dominant 250	  
late-onset Parkinson’s disease [104] (Table 2). The disease-associated mutations in CHCHD2 251	  
and CHCHD10 do not affect their C-terminal (CX9C)2 motifs and are rather clustered in an 252	  
internal evolutionary-conserved domain that they share with their yeast ancestor Mix17 253	  
(previously named Mic17; new nomenclature [80]) (Figure 2). Secondary structure analyses 254	  
(http://phobius.sbc.su.se, http://cho-fas.sourceforge.net) predict that internal hydrophobic 255	  
segments of CHCHD2 and CHCHD10 form helical structures (Figure 2C) and mediate 256	  
membrane binding. Of note, the pathogenic C176T mutation (S59L amino acid substitution) 257	  
in CHCHD10 might alter the secondary structure of this hydrophobic domain (Figure 2C) 258	  
and thus could perturb membrane binding. Nonetheless, it is conceivable that the above-259	  
mentioned domain could mediate interactions with other proteins that then would relay the 260	  
functional impact of pathogenic mutations. Yeast Mix17, the precursor of human CHCHD2 261	  
and CHCHD10, which is imported into the IMS in a Mia40/Erv1-dependent fashion, carries 262	  
at its N terminus a potential mitochondrial localization signal that is, however, not cleaved 263	  
during its import [46] (Figure 2). So far, there is no experimental evidence for the 264	  
functionality of this evolutionary-conserved N-terminal presequence in CHCHD10 or 265	  
CHCHD2 (Figure 2). Moreover, the implication of CHCHD4 in the import of CHCHD2 and 266	  
CHCHD10, possibly through oxidation of the C-terminal (CX9C)2 conserved motif (Figure 2), 267	  
remains to be formally demonstrated. However, the physical interaction between CHCHD4 268	  
and CHCHD2, as well as the inhibition of CHCHD2 expression by an ALR / ERV1 inhibitor 269	  
(MitoBloCK-6) [102, 105], strongly suggest that the import of CHCHD2 depends on the 270	  
CHCHD4/ALR system.  271	  
 272	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Overexpression of CHCHD2 results from increased gene transcription [106, 107] or from the 273	  
coamplification of CHCHD2 with EGFR in non-small cell lung cancer (NSCLC) [101] 274	  
(Table 2). CHCHD2 is a survival protein, and its depletion sensitizes cancer cells to 275	  
genotoxic chemotherapeutics and tyrosine kinase inhibitors [107]. In addition, CHCHD2 may 276	  
increase cellular migration [101, 108]. However, it remains to be understood through which 277	  
precise mechanisms CHCHD2 may contribute to malignancy. It should be noted that the 278	  
overexpression of CHCHD4 also correlates with increased severity of tumor grade and 279	  
reduced patient survival, a finding that has been related to the CHCHD4-mediated 280	  
stabilization of hypoxia-inducible factor 1α (HIF1α) [109] (Table 2). However, it is unknown 281	  
how CHCHD4 achieves this effect and whether CHCHD2 may affect HIF1α as well.  282	  
 283	  
Mitochondrial translation 284	  
Cells depleted of CHCHD4 (or of its interactor AIF) exhibit reduced expression of the 285	  
mtDNA-encoded CIV subunit COX2 [40, 62]. COX2 does not require mitochondrial import 286	  
because it is synthesized within the organelle, thus the mechanism through which CHCHD4 287	  
or AIF depletion could reduce COX2 expression was unclear. As a possibility, the expression 288	  
of COX2 could be low due to the decreased stability of CIV that results from nuclear DNA-289	  
encoded CIV subunits not being imported into the mitochondria. Alternatively, or in addition, 290	  
CHCHD4 might affect translation of COX2 via an indirect effect, through the regulation of 291	  
the import of its potential substrate CHCHD1 (Table 1), which is a component of the small 292	  
subunit of the mitochondrial ribosome [47, 49, 110]. The RNA-binding and (CX9C)2 motif-293	  
carrying protein CHCHD1 is the mammalian homolog of yeast Mrp10 [47, 49, 111]. The 294	  
import of Mrp10 into yeast mitochondria depends on an evolutionary-conserved N-terminal 295	  
presequence. However, the Mia40-catalyzed oxidation of cysteines in the (CX9C) 2 motif was 296	  
not required for the import or for the activity of Mrp10 and rather stabilized the protein within 297	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the matrix [112]. It will be important to investigate whether similar mechanisms apply to 298	  
human CHCHD1.  299	  
 300	  
Concluding remarks 301	  
The redox-regulated protein import machinery, composed of CHCHD4, AIF and ALR/ERV1, 302	  
is now established as a key player that couples the mitochondrial IMS to the cytoplasm and 303	  
other cellular compartments by catalyzing the oxidative import and/or folding of specific sets 304	  
of cysteine-rich substrates. Among these substrates, those that carry (CX9C)2 type motifs are 305	  
emerging as crucial factors implicated in a variety of mitochondrial functions.  306	   	  307	  
In mice, hypomorphic mutation of AIF (located on the X chromosome) or its organ-specific 308	  
knockout in liver or muscle causes resistance against high-fat diet-induced diabetes and 309	  
obesity, likely through subclinical defects in oxidative phosphorylation [113]. Heterozygous 310	  
knockout of CHCHD4 causes a similar phenotype, namely resistance to obesity [114], 311	  
suggesting that AIF and CHCHD4 are epistatic to each other. While full knockout of AIF or 312	  
CHCHD4 are embryonic lethal [40, 115], distinct AIF point mutations induce an array of 313	  
human diseases ranging from severe X-linked mitochondrial encephalomyopathy, Cowchock 314	  
syndrome (X-linked Charcot-Marie-Tooth disease with axonal sensorimotor neuropathy, 315	  
deafness and cognitive impairment) to infantile motor neuron disease or auditory neuropathy 316	  
spectrum disorder [116-119]. The fact that at least one of these pathogenic AIF mutations 317	  
(G308E, which gives rise to a severe phenotype) reduces AIF binding to CHCHD4 [40], 318	  
underscores the physiological importance of the AIF-CHCHD4 interaction. In this context, it 319	  
appears intriguing that many of the mutations in other CHCHD proteins (several of which are 320	  
CHCHD4 substrates) have been linked to phenotypes that are also affected by AIF, such as 321	  
propensity to diabetes and obesity, as well as a range of mitochondriopathies (Table 2). 322	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However, at this point it is not clear whether the massive dysfunction of respiratory chain 323	  
complexes caused by reduced AIF and CHCHD4 expression can be explained by the 324	  
downregulation of (CX9C)2-carrying CHCHD4 substrates or whether it is secondary to the 325	  
loss of other mitochondrial import proteins including the TIMM protein (such as the (CX3C)2 326	  
motif-containing protein DDPI).  327	  
The functional exploration of individual (CX9C)2 containing proteins will broaden our 328	  
understanding of cellular metabolism and of a range of inherited human diseases. Moreover, 329	  
the elucidation of the exact rules that govern the interactions among CHCHD4, AIF, ALR, 330	  
and each of the multiple CHCHD4 substrates (see outstanding questions) will be crucial for 331	  
the comprehension of this crucial molecular pathway. At present, it remains an enigma how 332	  
pathogenic mutations in AIF or CHCHD family proteins can give rise to highly organ-specific 333	  
phenotypes such as deafness or neurodegenerative disease. Hence, cell type and organ-334	  
restricted specificities in the CHCHD-dependent import pathways should be actively sought 335	  
out.  336	  
BOX	  1:	  Mia40/CHCHD4	  substrates	  337	  
  338	  
(CX3C)2 motif carrying Mia40 substrates: One of the earliest and best studied groups of 339	  
(Cx3C)2-containing Mia40 substrates in yeast corresponds to the family of small Tim proteins 340	  
[45], which are IMS-localized chaperone proteins with an average size of 10 kDa (Tim8, 341	  
Tim9, Tim10, Tim12 and Tim13). Tim proteins are organized in hetero-oligomeric complexes 342	  
and facilitate the mitochondrial import of hydrophobic membrane proteins by ushering them 343	  
from the outer membrane translocase to their final destination in the inner or outer membranes 344	  
[45]. All small Tim proteins (called TIMM in human cells) are correctly folded and matured 345	  
by two intramolecular disulfide bonds established between the cysteines of their twin CX3C 346	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motifs. Defective disulfide bond formation provokes their degradation by the mitochondrial 347	  
ATP-dependent protease Yme1 [120]. In mammalian cells, the loss of AIF disturbs the 348	  
mitochondrial import of CHCHD4 and consequently impacts the biogenesis of TIMM8A 349	  
(also known as DDP1) [40], which is one member of the highly conserved small TIMM 350	  
family [121]. In human cells, deletion or loss-of-function mutations in the gene encoding 351	  
DDP1/TIMM8A is responsible for a rare X-linked recessive neurological disorder called 352	  
deafness-dystonia or Mohr-Tranebjaerg syndrome [122]. One such loss-of-function mutation 353	  
causes the replacement of a cysteine by a tryptophan (C66W) within the CX3C motif, 354	  
preventing the correct folding of DDP1 and consequently its ability to participate in 355	  
mitochondrial import reactions [123].  356	  
 357	  
(CX9C)2 motif carrying Mia40 substrates: See section “C-X9-C domain-containing proteins 358	  
in health and disease” in the main text. 359	  
. 360	  
 361	  
Other Mia40 substrates: Recent studies have revealed that the interaction of Mia40 with 362	  
substrate proteins is not limited to CXnC-containing precursors but also includes proteins with 363	  
alternate cysteine motifs that are not organized structurally in a CHCH domain and are larger 364	  
in size. One example is the 27 kDa copper chaperone Ccs1, which contains a 365	  
CX2CX6CX36CXnC motif [124]. Other examples are Erv1 itself, which contains a CX15C motif 366	  
[125], and the Fe/S cluster protein Dre2 (human orthologue: Anamorsin) [126]. Several novel 367	  
Mia40 substrates were recently shown to rely on the chaperone activity of Mia40 rather than 368	  
on its redox activity. Although the proteolytic activity of the mitochondrial inner membrane 369	  
protease Atp23 requires formation of five disulfide bonds, its import can occur independently 370	  
of oxidation [127]. In this case, the hydrophobic cleft of Mia40, rather than the redox active 371	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CPC tripeptide, is critical for Atp23 import. Mia40/CHCHD4 also chaperones the Tim22 372	  
protein, a polytopic protein that integrates into the IM through multiple transmembrane 373	  
segments and functions as a membrane insertase and the key component of the TIM22 374	  
complex [128]; the matrix-targeted protein Mrp10 [112], which is a subunit of the 375	  
mitochondrial ribosome; and APE1, a protein involved in the repair of damaged nuclear and 376	  
mtDNA [129].  377	  
Yet another type of Mia40/CHCHD4 substrate is represented by MICU1, a mitochondrial 378	  
regulator of the Ca2+ uniporter (MCU)[130]. In human cells, the import of MICU1 in the IMS 379	  
requires an N-terminal targeting sequence while its interaction with CHCHD4 and cysteine 380	  
oxidation are secondary to its membrane potential-dependent import [130]. This latter 381	  
example underscores the versatile implication of the Mia40/CHCHD4 system in multiple 382	  
distinct import pathways. 383	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Figure 1, Key figure.  
Left panel: Schematic representation of the CHCHD4/MIA40-regulated import pathway in 
metazoan mitochondria. Nuclear-encoded substrates carrying (CX3C)2 or (CX9C)2 motifs 
carrying or other cysteine-rich proteins are translated by cytoplasmic ribosomes and imported, 
in their reduced form, into the inter membrane space (IMS), through the outer membrane 
localized TOM translocase. In the IMS, the oxidase CHCHD4/MIA40 that is bound to the 
flavoprotein AIF regulates the import and/or the post-import folding of the substrates by 
catalyzing the formation of disulfide bonds. Electrons (red arrow) generated by the oxidation 
of the substrate are transferred to the CPC motif of CHCHD4/MIA40, to ALR, to cytochrome 
C (Cyto C), to complex CIV and oxygen (O2). A direct transfer of electron from ALR to O2 is 
an alternative possibility. Electron flow generated by the activity of the respiratory chain 
complexes is also depicted (red arrow). 
Right panel: The mitochondrion-imported (CX9C)2 motifs-carrying substrates participate to a 
vast spectrum of activities that include protein import, lipid homeostasis, mitochondrial 
ultrastructure and dynamics, Ca2+ storage, respiratory chain complexes biogenesis and 
assembly and mitochondrial protein translation. The correct functioning of the 
CHCHD4/MIA40 substrates affects the cellular bioenergetics, metabolism and response to 
stress conditions caused by hypoxia or apoptotic signals. 	  
Figure 2. Protein sequence analyses of human CHCHD10 and CHCHD2. 
(A) Phylogenetic analyses of metazoan CHCHD10 and CHCHD2 and yeast Mix17. Multiple 
alignments of protein sequences available from public databases, using the Clustal Omega 
program, reveal three protein domains conserved between yeast Mix17 and its metazoan 
homologs CHCHD10 and CHCHD2. The first N-terminal conserved domain is positively 
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charged and harbors a potential mitochondrial localization presequence. The second 
conserved region is central and enriched in hydrophobic residues. The third conserved 
segment is located in the C terminus of the polypeptides and carries the cysteine-enriched 
(CX9C)2 motif. UniProt identifiers for analyzed protein sequences are the following: H. 
sapiens CHCHD10 (Q8WYQ3), P. troglodyte CHCHD10 (K7D2L2), B. Taurus CHCHD10 
(A4IF72), M. musculus CHCHD10 (Q7TNL9), X. tropicalis CHCHD10 (F7CKM8), D. rario 
CHCHD10 (Q6PBP6), H. sapiens CHCHD2 (Q9Y6H1), P. troglodyte CHCHD2 (H2QUM2), 
B. Taurus CHCHD2 (Q3ZCI0), M. musculus CHCHD2 (Q9D1L0), X. tropicalis CHCHD2 
(Q68ER0), D. rario CHCHD2 (NP_957061.1), and S. cerevisiae MIX17 (Q03667).	  
(B) Identification of disease-associated mutations in the central conserved hydrophobic 
domain of human CHCHD10 and CHCHD2. Within the central conserved segment of human 
CHCHD10 and CHCHD2 (identified in figure 1), the positions for each reported mutation 
and the corresponding amino acid substitution are shown (see also Table 3 for the references). 
The variant H78N for CHCHD2 corresponds to a natural variant identified in the SNP 
database (rs11546418; uniprot identifier VAR_048699). 
(C) Prediction of secondary structural characteristics for wild type (wt) and mutant (S59L) 
human CHCHD10. Entire primary amino acid sequences of the wt and S59L variant of 
human CHCHD10 were analyzed using the GOR IV secondary structure prediction program 
(https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_gor4.html), and only the 
central conserved hydrophobic segment that includes the wt or mutated (S59L) residue is 
shown. C (random coil), h (alpha helix), e (extended strand). 
 
 
 
 
